Please provide your email address to receive an email when new articles are posted on . Use of decentralized elements in cancer clinical trials did not have long-term negative effects on data quality.

Milliman MedInsight (R) (MedInsight), a leading healthcare data and analytics division of Milliman, is entering 2026 with accelerating momentum in value-based care. Milliman MedInsight has earned ...

For children with established AD and food allergies, early systemic therapy, including dupilumab and JAK inhibitors, may interrupt progression along the atopic march, with data supporting both ...

In today’s ACT Brief, we examine how large de-identified datasets are reshaping trial design and site strategy, why global ...

Report shows completing manual data reconciliation, cleaning, and review takes each data manager more than 12 hours per week, per study Each round of manual data review, cleaning, and reconciliation ...

Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. In the last decade, the volume of clinical trial data has surged, presenting unprecedented ...

Payer-provider clinical data exchange plays a critical role in payer operations, helping streamline workflows and improve patient care. Traditionally, this exchange ...

For the tenth year, CMS named McKesson a Qualified Clinical Data Registry approved to participate in the Merit-based ...

Physicians, struggling under the pressure of heavy patient loads amidst a national clinical workforce shortage, continue to rank working with EHR systems as the second most challenging part of the job ...

Despite rapid growth, only 9.2% of DCTs are multiregional and over 80% single-country, indicating challenges in international implementation. 2 With regulatory agencies 4–7 underscoring risk-based ...